News Focus
News Focus
icon url

cjgaddy

09/15/12 12:42 PM

#92516 RE: cjgaddy #92513

Bob, for 1st-Line NSCLC, also recall FTM’s Tables for P+C/Alone prev. Trials in Front-Line NSCLC…
• The mean MOS is 9.8 mos. for the 12 trials (range 8.1 – 13.0)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76905176


= = = = = = = = = = = = = =
Look at the MOS reported for the P+C/Alone arm in this Avastin trial:
(P+C = Paclitaxel + Carboplatin)
AVASTIN E4599/n=434 Ph.III Trial in Front-Line NSCLC:
P+C/alone = 10.3 mos.
• Avastin+PC=12.3 mos.
From: http://www.nejm.org/doi/pdf/10.1056/NEJMoa061884
icon url

Robert C Jonson

09/15/12 12:43 PM

#92517 RE: cjgaddy #92513

CJ, that looks convincing, so it looks very much like the 1st line control arm MOS should have been reached by now. Hope you hear something from IR.

THanks!

Bob